氨磺必利与阿立哌唑对首发精神分裂症患者血糖及血清泌乳素水平的影响
被引量:10
摘要
我们对氨磺必利及阿立哌唑治疗精神分裂症血糖(FBG)及血清泌乳素(PRL)水平影响做初步研究,为临床合理用药提供参考。
出处
《临床精神医学杂志》
2015年第2期116-116,共1页
Journal of Clinical Psychiatry
参考文献1
-
1闫俊,张鸿燕,舒良,李华芳,顾牛范,王刚,蔡焯基,肖卫东,王高华,谢世平,张心保,李婷,马崔,姚晨.阿立哌唑与利培酮治疗精神分裂症的随机双盲多中心对照研究[J].中华精神科杂志,2008,41(2):81-84. 被引量:22
二级参考文献10
-
1Marcus R, Kostic D, McQuade R. et al. Efficacy and safety of intramuscular aripiprazole, haloperidol or placebo in acutely agitated patients with schizophrenia or schizoaffective disorder [ J/ OL]. Schizophr Bull, 2005,31 (2) :499 [ 2007-12-19 ]. http:// gateway, tx. ovid. com.
-
2Potkin SG, Saha AR, Kujawa MJ, et al. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry., 2003, 60:681-690.
-
3Pigott TA, Carson WH, Saha AR, et al. Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study. J Clin Psychiatry., 2003, 64:1048-1056.
-
4Chrzanowski WK, Marcus RN, Torbeyns A, et al. Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine. Psychopharrnacology ( Berl ), 2006, 159 : 259- 266.
-
5Cassano GB, Fagiolini A, Lattanzi L, et al. Aripiprazole in the treatment of schizophrenia: a consensus report produced by schizophrenia experts in Italy. Clin Drug Investig, 2007, 27 : 1- 13.
-
6Tandon R, Marcus RN, Stock EG, et al. A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: broad effectiveness trial with aripiprazole ( BETA ) . Schizophr Res, 2006, 84:77-89.
-
7Bardin L, Auclair A, Kleven MS, et al. Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/ serotonin 5-HT1A activity conventional antipsychotics. 118. comparison with typical and atypical Behav Pharmacol, 2007, 18: 103-
-
8Jordan S, Koprivica V, Chen R, et al. The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor. Eur J Pharmacol, 2002, 441 : 137-140.
-
9Horacek J, Bubenikova-Valesova V, Kopecek M, et al. Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS Drugs ,2006, 20:389-409.
-
10Naber D, Lambert M. Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism. Prog Neuropsychopharmacol Biol Psychiatry, 2004, 28:1213-1219.
共引文献21
-
1谢根生,赵新蕾,钱国平,吴玉红,胡庆芬.阿立哌唑与利培酮治疗精神分裂症对照研究[J].中国预防医学杂志,2010,11(2):190-192. 被引量:1
-
2司天梅,王刚.临床试验方法的选择:有效性研究和疗效研究[J].中华精神科杂志,2010,43(1):1-2. 被引量:1
-
3王金龙,赵和丹,姚明荣,夏江明.阿立哌唑与利醅酮治疗精神分裂症的疗效和安全性对照研究[J].临床精神医学杂志,2011,21(1):7-7. 被引量:6
-
4崔菁.阿立哌唑与利培酮治疗首发精神分裂症的对照研究[J].中国药物与临床,2012,12(6):787-789. 被引量:17
-
5许锦泉,唐旭,朱宏昌.阿立哌唑与利培酮治疗精神分裂症对照研究[J].临床心身疾病杂志,2013,19(2):109-111. 被引量:19
-
6李伟,廉世松.阿立哌唑治疗精神分裂症的疗效及安全性探讨[J].中外医疗,2013,32(9):97-98. 被引量:8
-
7程闯,张新风.阿立哌唑合并康复训练改善精神分裂症患者生活质量的临床研究[J].中国医学创新,2013,10(13):34-36. 被引量:12
-
8杨永秀,陈斌华,徐小杰,陶云海,施剑飞.阿立哌唑联合利培酮治疗慢性精神分裂症对照研究[J].中国临床药理学杂志,2013,29(6):419-422. 被引量:37
-
9孟月兰,张慧英,彭旭.阿立哌唑与氯氮平治疗精神分裂症对照研究[J].中国实用神经疾病杂志,2013,16(13):39-41. 被引量:1
-
10喻伯强.国产利培酮片治疗精神分裂症的疗效及安全性[J].中国实用医刊,2013,40(23):114-115. 被引量:1
同被引文献70
-
1文斌,李文华,章秋明,曹青.阿立哌唑与利培酮治疗精神分裂症对照研究[J].临床精神医学杂志,2006,16(1):49-50. 被引量:74
-
2Sun J, Tang Y, Lim KO, et ah Abnormal Dynamics of EEG Oscillations in Schizophrenia Patients on Multiple Time Scales. IEEE Transactions on Biomedical Engineering, 2014, 61 (6): 1756-1764.
-
3Chuang CC, Nakagome K, Pu SH, et al. Discriminant analysis of functional optical topography for schizophre- nia diagnosis.Journal of biomedical optics, 2014, 19 ( 1 ): 011006-1-011006-6.
-
4A Genetically Informed, Group fMRI Connectivity Modeling Approach: Application to Schizophrenia.IEEE Transactions on Biomedical Engineering, 2014, 61 (3): 946-956.
-
5Maglione JE, Thomas SE, Jeste DV, et al. Late-onsetschizophrenia: Do recent studies support categorizing LOS as a subtype of schizophrenia?. Current opinion in psychiatry, 2014, 27 (3): 173-178.
-
6Luo X, Huang L, Jia P, et al. Protein-protein interaction and pathway analyses of top schizophrenia genes reveal schizo- phrenia susceptibility.Schizophrenia bulletin, 2014, 40 ( 1 ): 39-49.
-
7Perez-Becerril C, Morris AG, Mortimer A, et al. A11elic variants in the zinc transporter-3 gene, SLC30A3, a can- didate gene identified from gene expression studies, show gender-specific association with schizophrenia. European psychiatry: the journal of the Association of European Psychia- trists, 2014, 29 (3): 172-178.
-
8Bakken T, Kang SW, Kosonsiriluk S, et al. Differential roles of hypothalamic serotonin receptor subtypes in the regula- tion of prolactin secretion in the turkey hen.ActaHistochemica: Zeitschrift fur Histologische Topochemie, 2014, 116 ( 1 ): 131-137.
-
9Devi YS, Halperin J. Reproductive actions of prolactin medi- ated through short and long receptor isoforms.Molecular and Cellular Endocrinology, 2014, 382 ( 1 ): 400-410.
-
10许又新.对《精神分裂症防治指南》的意见[J].中国心理卫生杂志,2011,25(1):26-27. 被引量:25
引证文献10
-
1胡建高,朱敏.氨磺必利片、阿立哌唑片对首发精神分裂症糖脂代谢的影响[J].现代诊断与治疗,2015,26(24):5576-5577.
-
2杨淑珍,赵晶媛,孙丽新,王亚丽.氨磺必利对首发精神分裂症患者泌乳素的影响[J].国际精神病学杂志,2016,43(3):415-417. 被引量:6
-
3沙建敏,张伟,丁景景,陈光东,杨亚芳.男性精神分裂症患者小剂量阿立哌唑联合氨磺必利治疗对性功能、催乳素的影响[J].中国农村卫生事业管理,2017,37(3):356-358. 被引量:6
-
4肖志平.氨磺必利治疗首发精神分裂症的临床疗效研究[J].基层医学论坛,2017,21(16):2055-2056. 被引量:1
-
5苏丽娟.氨磺必利联合低频重复经颅电刺激对首发精神分裂症患者血清Leptin水平及椎体外系不良反应的影响[J].国际医药卫生导报,2018,24(4):498-500. 被引量:4
-
6王华阳,杨献红,黄瑛,张婕文.小剂量阿立哌唑联合氨磺必利对男性精神分裂症患者临床症状及性功能、催乳素的影响[J].国际精神病学杂志,2018,45(4):604-607. 被引量:16
-
7周为,姚静,龙吟,肖英,杨兴菊.氨磺必利对改善精神分裂症患者阴性症状及生活质量的效果分析[J].临床心身疾病杂志,2019,25(2):86-88. 被引量:1
-
8谢穗峰.阿立哌唑联合氨磺必利对精神分裂症住院患者脂代谢及甲状腺激素水平的影响观察[J].中国医药科学,2020,10(8):46-49. 被引量:6
-
9孙建华,范伟.氨磺必利与阿立哌唑治疗女性精神分裂症对催乳素、甲状腺功能的影响[J].临床合理用药杂志,2020,13(14):90-91. 被引量:7
-
10杨静艳.氨磺必利联合阿立哌唑对女性精神分裂症患者的疗效分析[J].世界最新医学信息文摘,2018,18(73):124-124.
二级引证文献43
-
1杨庆林,张翔,张九英,胡慧娟,苏成法.氨磺必利治疗精神分裂症的临床疗效观察[J].智慧健康,2020(34):95-97. 被引量:1
-
2卜琴芳,陈方斌,张李婉.研究氨磺必利对精神分裂症患者催乳素水平的影响[J].心理月刊,2021(22):98-100. 被引量:1
-
3夏龙德.氨磺必利和小剂量阿立哌唑联合治疗精神分裂症的效果研究[J].世界最新医学信息文摘,2020(65):100-100.
-
4杨翔,汪海珍.氨磺必利联合阿立哌唑治疗女性精神分裂症患者的疗效及安全性[J].临床合理用药杂志,2018,11(34):61-62. 被引量:1
-
5黄景源,张倩颖,丁虹.杨梅素对小鼠髓鞘损伤精神分裂症样行为学的研究[J].中国农学通报,2017,33(9):141-145. 被引量:4
-
6丁力,陶明.氟哌噻吨治疗男性无自知力精神分裂症伴高泌乳素血症疗效研究[J].中国药业,2017,26(5):41-44.
-
7姚雪阳,汤世明,蔡枫,常程.影响首发老年精神分裂症患者预后不良的危险因素[J].国际精神病学杂志,2017,44(3):406-410. 被引量:10
-
8李庆梅,李娜,蔡雪梅.氨磺必利与利培酮在女性首发精神分裂症患者认知功能中的疗效分析[J].中国卫生标准管理,2018,9(2):89-90. 被引量:5
-
9尹雪梅.氨磺必利对阴性症状为主精神分裂症患者认知功能的影响研究[J].智慧健康,2018,4(5):138-139.
-
10潘伟盟.老年精神分裂症患者肺部感染的临床特征及应对措施探讨[J].国际医药卫生导报,2018,24(21):3305-3307. 被引量:6
-
1胡春霞,王海龙.齐拉西酮与利培酮治疗首发儿童青少年精神分裂症对照研究[J].临床心身疾病杂志,2016,22(1):52-54. 被引量:4
-
2张述杰,王美娟.阿立哌唑与利培酮治疗80例女性精神分裂症患者的对照研究[J].中国民康医学,2011,23(13):1598-1599. 被引量:1
-
3关健伟,巫志明,凌蓓蒂,梁明识.癫痫发作间期血清泌乳素水平的研究[J].临床神经病学杂志,1993,6(2):108-109. 被引量:1
-
4陈丽娜.喹硫平与舒必利对精神分裂症患者血清泌乳素水平的影响[J].临床心身疾病杂志,2010,16(2):104-106. 被引量:4
-
5甄莉丽,李金香.帕利哌酮缓释片与齐拉西酮治疗对精神分裂症患者血清泌乳素及体质量的影响[J].中国健康心理学杂志,2012,20(12):1766-1768. 被引量:2
-
6郭光辉.阿立哌唑治疗男性精神分裂症患者的临床观察[J].中国中医药咨讯,2011,3(7):8-9. 被引量:1
-
7左懿.辛伐他汀对急性脑梗死患者血脂 高敏C反应蛋白水平影响分析[J].中国实用神经疾病杂志,2014,17(21):83-84. 被引量:1
-
8刘丰.依达拉奉联合丹参注射液对急性脑梗死患者血清Hcy的影响[J].中国临床研究,2014,27(12):1485-1486. 被引量:8
-
9王慧,洪美娜,高镇松,许家超.精神分裂症患者血清泌乳素水平与性相关精神症状对照研究[J].临床心身疾病杂志,2010,16(3):193-195. 被引量:6
-
10马德,李丽.齐拉西酮对首发精神分裂症患者糖脂代谢和血清泌乳素的影响[J].临床精神医学杂志,2017,27(1):60-60. 被引量:12